Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114169363 | 11416936 | 3 | F | 201407 | 20160824 | 20150825 | 20160824 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-21587233 | BRISTOL MYERS SQUIBB | 22.98 | YR | F | Y | 88.00000 | KG | 20160824 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114169363 | 11416936 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 30 MG, QD | 21436 | 30 | MG | TABLET | QD | ||||||
| 114169363 | 11416936 | 2 | C | LARGACTIL /00011901/ | CHLORPROMAZINE | 1 | Unknown | 25 MG, QD | U | 0 | 25 | MG | QD | ||||||
| 114169363 | 11416936 | 3 | C | IMOVANE | ZOPICLONE | 1 | Unknown | UNK UNK, PRN | U | 0 | |||||||||
| 114169363 | 11416936 | 4 | C | GAVISCON /00237601/ | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 114169363 | 11416936 | 5 | C | SPASFON /00765801/ | PHLOROGLUCINOL1,3,5-TRIMETHOXYBENZENE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114169363 | 11416936 | 1 | Schizophrenia |
| 114169363 | 11416936 | 2 | Product used for unknown indication |
| 114169363 | 11416936 | 3 | Product used for unknown indication |
| 114169363 | 11416936 | 4 | Product used for unknown indication |
| 114169363 | 11416936 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114169363 | 11416936 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114169363 | 11416936 | Caesarean section | |
| 114169363 | 11416936 | Live birth | |
| 114169363 | 11416936 | Maternal exposure during pregnancy | |
| 114169363 | 11416936 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114169363 | 11416936 | 1 | 201111 | 0 |